| 物质名称 | UPROSERTIB |
|---|
| 异名/同义词 | 2-FURANCARBOXAMIDE, N-((1S)-2-AMINO-1-((3,4-DIFLUOROPHENYL)METHYL)ETHYL)-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-
AKT INHIBITOR GSK2141795
AKT INHIBITOR GSK-2141795
GSK2141795
GSK2141795C
GSK-2141795C
N-((1S)-1-(AMINOMETHYL)-2-(3,4-DIFLUOROPHENYL)ETHYL)-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)FURAN-2-CARBOXAMIDE
UPROSERTIB
UPROSERTIB [INN]
UPROSERTIB [USAN]
UPROSERTIB [WHO-DD]
|
|---|
| CAS登记号 | 1047634-65-0 |
|---|
| 物质唯一标识(Unique Ingredient Identifier) | ZXM835LQ5E |
|---|
| 分子式 | C18H16Cl2F2N4O2 |
|---|
| 国际化合物标识(International Chemical Identifier,InChI) | AXTAPYRUEKNRBA-JTQLQIEISA-N |
|---|
| SMILES | o1c(cc(c1Cl)-c2c(cnn2C)Cl)C(=O)N[C@H](CN)Cc3cc(c(cc3)F)F |
|---|
| 分子结构式 |  |
|---|
| 欧洲化学品管理局注册号(ECHA) | |
|---|
| 成分类型 | INGREDIENT SUBSTANCE / chemical |
|---|
| 关联数据 | |
|---|
| 扩展资源 | |
|---|